Nulixir's Nusome™ technology enhances probiotic stability in low pH environments, improving survival rates and reducing input material. This technology protects probiotics through the GI tract and enables targeted release, enhancing product efficacy.
Nulixir presents an innovative encapsulation technology, the Nusome™, designed to significantly improve the stability and survival rates of probiotics in low pH food and beverage applications. By encasing fragile probiotics in a protective Nusome shell, this technology not only enhances the stability of probiotics against environmental stressors such as moisture, air, and heat but also ensures their safe passage through the gastrointestinal tract. Additionally, the surface of Nusomes can be functionalized to enable targeted release, thereby enhancing the efficacy of probiotic products.
The Nusome™ technology is currently at Technology Readiness Level 5, indicating that it has been validated in a relevant environment. Future steps include further testing for shelf life stability, slow release, and pH stability, followed by clinical trials to demonstrate efficacy and bioavailability.
Nulixir is a Texas-based company founded in 2019, specializing in advanced nutritional solutions for the food, beverage, and nutraceutical industries. The company develops and licenses proprietary encapsulation technologies to optimize ingredient performance, enhance bioavailability, and enable controlled release, supporting the development of next-generation functional products.